-
-
-
-
-
-
-
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
-
-
-
-
-
-
-
Myriad Genetics Reports Second Quarter Financial Results
-
-
-
-
-
-
-
Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
-
-
-
-
-
-
-
Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q3 EPS by 8c
-
939,988 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All